Profound Research
Profound Research operates a network of 22 clinical research sites across four U.S. geographies, running 130+ trials for pharmaceutical sponsors across 15+ therapeutic areas and connecting 1.25M+ patients with 1,000+ provider-investigators.
- Company typePrivate
- Founded2023
- HeadquartersNashville, United States
- Headcount51–100
- GTM typeB2B
- OfferingServices
What Profound Research does
Profound Research operates a clinical research site network that connects three customer segments — patients seeking trials, pharmaceutical and biotech sponsors running trials, and community healthcare providers participating as investigators — through a coordinated multi-region infrastructure. The company runs 22 clinical research sites across four geographies with 110+ active investigators covering 15+ therapeutic areas, with cardiology and dermatology called out as primary specialties. It maintains a combined network database of 1.25+ million patients and 1,000+ providers, and has conducted 130+ clinical trials through the site network.
The core platform is a clinical research site network infrastructure rather than a standalone software product. Services include patient clinical trial matching via a website portal (where patients search by location), sponsor capabilities including site management and trial execution, and a provider partnership program that recruits community physicians to serve as investigators. The technology differentiator cited is scale and reliability of an integrated site network, supported by the centralized patient and provider database that enables faster enrollment than single-site operators. A Refer-A-Friend program supports patient acquisition, and dedicated contact forms for sponsors and providers structure enterprise sales onboarding.
Profound Research generates revenue through professional-services contracts with pharmaceutical and biotech sponsors for clinical trial execution, site management, and patient recruitment through its provider network. Pricing is not publicly disclosed and is contracted bespoke per trial, which is standard for the clinical trial services market. The company operates as Profound Research LLC, headquartered at 220 Athens Way, Suite 240A, Nashville, TN, with 11–50 employees and a national U.S. operating footprint.
Profound Research firmographics
Firmographics- Name
- Profound Research
- Legal name
- Profound Research LLC
- Website
- https://profoundresearch.io
- Company type
- Private
- Founded year
- 2023
- Operating status
- Operating
- Headcount range
- 51–100 employees
- Short description
- Profound Research operates a network of 22 clinical research sites across four U.S. geographies, running 130+ trials for pharmaceutical sponsors across 15+ therapeutic areas and connecting 1.25M+ patients with 1,000+ provider-investigators.
- Ownership category
- akta.pro rank
Profound Research industry classification
Industry- Product category
- Clinical Research Services
- NAICS
- Scientific Research and Development Services (5417)
- SIC
- Services-Commercial Physical & Biological Research (8731)
- akta.pro industry
- Clinical Trial Site Operations & Study CoordinationHealthcare & Life Sciences/Life Science Tools & Services (CRO/CDMO/Lab Services)/Clinical Trial Services & Site Management (SMO)
Keywords
Where Profound Research is headquartered
LocationHeadquarters
- HQ city
- Nashville
- HQ country
- United States
- HQ region
- North America
Offices1 record
Markets served
Profound Research business model
Business model- GTM type
- B2B
- Offering type
- Services
- Cost components
- Personnel, Operations, Technology or R&D, Marketing or Sales, Infrastructure
Revenue model
- Clinical Trial Services: Revenue generated from conducting clinical trials on behalf of pharmaceutical and biotech sponsors. Services include site management, patient recruitment through the provider network, and trial execution across therapeutic areas.
Go-to-market motion1 record
Distribution channels3 records
Marketing channels3 records
Profound Research product offering
Product offeringCore offering
Profound Research operates an integrated network of 22 clinical research sites across four geographies that conducts clinical trials on behalf of pharmaceutical and biotech sponsors. The company connects patients to clinical studies through a combined database of 1.25+ million patients and 1k+ providers, while enabling healthcare providers to participate as investigators. The network covers 15+ therapeutic areas with primary focus on cardiology and dermatology, having executed 130+ clinical trials through the site network.
Product overview
Profound Research operates as a clinical research network offering an integrated platform of services connecting patients, sponsors, and healthcare providers. The core offerings include a patient-facing clinical trial matching service, a network of 22 research sites with 110+ investigators spanning 15+ therapeutic areas (notably cardiology and dermatology), sponsor capabilities for pharmaceutical companies seeking to conduct clinical trials, and a provider partnership program. The company manages a combined network database of 1.25+ million patients and has conducted 130+ clinical trials through its site network.
Differentiator
Problem solved
Functional benefit
Products and services
- Patient Clinical Trial Matching
- Clinical Research Site Network
- Sponsor Capabilities Services
- Provider Partnership Program
Companies that use Profound Research
Customer profileSegments3 records
Ideal customer profiles3 records
Profound Research technology and API
TechnologyTechnology focussed No
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
Feature1 record
Profound Research partnerships and signals
Strategic signalScale indicators6 records
Recent moves4 records
Expansion highlights4 records
Profound Research competitors and assessment
Company assessmentDirect peers
- Velocity Clinical Research: Velocity is an integrated clinical research site network operating dozens of locations across the US, conducting multi-therapeutic trials on behalf of pharma sponsors. It is the closest direct competitor to Profound's 22-site, multi-therapeutic site network model.
- CenExel: CenExel operates a network of clinical research sites across the US focused on early-phase and specialty trials in CNS, pain, and other therapeutic areas. It competes directly with Profound for sponsor trials requiring multi-site execution and integrated site operations.
- Javara Research: Javara is an integrated research organization that embeds clinical trial capabilities into community physician practices, mirroring Profound's model of enabling community physicians to offer research as a care option. Both compete for community-based trial execution partnerships.
- Circuit Clinical: Circuit Clinical operates a multi-site clinical research network with integrated patient identification and trial execution services. It is comparable to Profound in offering sponsors a single-contract, multi-site solution with a centralized patient database.
- Accel Research Sites: Accel Research Sites is a multi-therapeutic, multi-site clinical research network serving pharmaceutical sponsors across the US. It competes with Profound for cardiology, dermatology, and other specialty Phase 2–4 trial placements.
- Sarah Cannon Research Institute: Sarah Cannon is HCA Healthcare's oncology-focused clinical research site network and one of the largest US site organizations. It is comparable to Profound as a sponsor-facing, multi-site clinical trial execution platform, although concentrated in oncology.
- US Oncology Research: US Oncology Research, part of McKesson, is a community-based clinical research site network that enrolls patients into oncology trials through affiliated physician practices. It shares Profound's community-physician-anchored site network model.
Broad incumbents
- Medpace: Medpace is a mid-to-large global CRO that runs full-service clinical trials, including site management and patient recruitment across multiple therapeutic areas. It competes with Profound at the sponsor level for trial execution work, although it operates as a full-service CRO rather than a dedicated site network.
- IQVIA: IQVIA is the world's largest CRO with global site network capabilities, real-world data assets, and decentralized trial technology. It competes with Profound for sponsor site selection and represents the upper bound of scale in the clinical trial execution market.
- Fortrea: Fortrea is a global CRO spun out of Labcorp's clinical development business, offering clinical trial management, site services, and patient recruitment. It competes with Profound for sponsor site-based trial work, though it operates as a broader services provider.
Market position
Strengths4 records
Weaknesses5 records
Competitive moat4 records
Key risks5 records
Key highlights6 records
Customer concentration
Profound Research social profiles
Digital presenceProfound Research financial estimates
Financial estimateRevenue estimate
Valuation estimate
Profound Research leadership team
Management profileNumber of profiles
Profound Research funding detail
Funding detailFunding overview
Funding rounds1 record
Investors1 record
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
Profound Research M&A and investment
M&A and investmentM&A
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about Profound Research
What does Profound Research do?
Profound Research operates an integrated network of 22 clinical research sites across four geographies that conducts clinical trials on behalf of pharmaceutical and biotech sponsors. The company connects patients to clinical studies through a combined database of 1.25+ million patients and 1k+ providers, while enabling healthcare providers to participate as investigators. The network covers 15+ therapeutic areas with primary focus on cardiology and dermatology, having executed 130+ clinical trials through the site network.
When was Profound Research founded?
Profound Research was founded in 2023. It employs 51 to 100 people.
Where is Profound Research based?
Profound Research is headquartered in Nashville, United States, in the North America region.
How does Profound Research make money?
One revenue line is on record: clinical Trial Services.
Who are Profound Research's main competitors?
Direct peers on record are Velocity Clinical Research, CenExel, Javara Research, Circuit Clinical, Accel Research Sites, Sarah Cannon Research Institute and US Oncology Research. Broad incumbents are Medpace, IQVIA and Fortrea.
Does Profound Research have an API?
No public API is recorded for Profound Research.
What industry is Profound Research in?
Profound Research's product category is Clinical Research Services. Its primary akta.pro industry code is HLAGACAE, Clinical Trial Site Operations & Study Coordination. Its NAICS code is 5417 and its SIC code is 8731.